Literature DB >> 23906377

Natural killer cell biology: an update and future directions.

Kerry S Campbell1, Jun Hasegawa2.   

Abstract

Natural killer (NK) cells constitute a minor subset of normal lymphocytes that initiate innate immune responses toward tumor and virus-infected cells. They can mediate spontaneous cytotoxicity toward these abnormal cells and rapidly secrete numerous cytokines and chemokines to promote subsequent adaptive immune responses. Significant progress has been made in the past 2 decades to improve our understanding of NK cell biology. Here we review recent discoveries, including a better comprehension of the "education" of NK cells to achieve functional competence during their maturation and the discovery of "memory" responses by NK cells, suggesting that they might also contribute to adaptive immunity. The improved understanding of NK cell biology has forged greater awareness that these cells play integral early roles in immune responses. In addition, several promising clinical therapies have been used to exploit NK cell functions in treating patients with cancer. As our molecular understanding improves, these and future immunotherapies should continue to provide promising strategies to exploit the unique functions of NK cells to treat cancer, infections, and other pathologic conditions.
Copyright © 2013 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.

Entities:  

Keywords:  ADCC; AML; Acute myeloid leukemia; Antibody-dependent cellular cytotoxicity; CAR; Chimeric antigen receptor; Class I MHC; HSC; Hematopoietic stem cell; IFN-γ; ILC; ITIM; Immunoreceptor tyrosine-based inhibitory motif; Innate lymphoid cell; KIR; Killer cell immunoglobulin-like receptor; MCMV; MHC-I; MM; Mouse cytomegalovirus; Multiple myeloma; NCR; NK; Natural cytotoxicity receptor; Natural killer; Natural killer cell; PD-1; Programmed cell death 1; SRIR; Self-recognizing inhibitory receptor; antibody-dependent cellular cytotoxicity; cancer; hematopoietic stem cell transplantation; immune memory; immunomodulatory drugs; innate immunity; killer cell immunoglobulin-like receptors; viral infection

Mesh:

Substances:

Year:  2013        PMID: 23906377      PMCID: PMC3775709          DOI: 10.1016/j.jaci.2013.07.006

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  115 in total

Review 1.  Natural killer cells: a review of manufacturing and clinical utility.

Authors:  Scott A Koepsell; Jeffrey S Miller; David H McKenna
Journal:  Transfusion       Date:  2012-06-07       Impact factor: 3.157

2.  T cell- and B cell-independent adaptive immunity mediated by natural killer cells.

Authors:  Jacqueline G O'Leary; Mahmoud Goodarzi; Danielle L Drayton; Ulrich H von Andrian
Journal:  Nat Immunol       Date:  2006-04-16       Impact factor: 25.606

3.  Cytokine-induced memory-like natural killer cells.

Authors:  Megan A Cooper; Julie M Elliott; Peter A Keyel; Liping Yang; Javier A Carrero; Wayne M Yokoyama
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-30       Impact factor: 11.205

4.  A Role for cis Interaction between the Inhibitory Ly49A receptor and MHC class I for natural killer cell education.

Authors:  Anick Chalifour; Léonardo Scarpellino; Jonathan Back; Petter Brodin; Estelle Devèvre; Frédéric Gros; Frédéric Lévy; Georges Leclercq; Petter Höglund; Friedrich Beermann; Werner Held
Journal:  Immunity       Date:  2009-03-20       Impact factor: 31.745

5.  CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity.

Authors:  Todd A Fehniger; Megan A Cooper; Gerard J Nuovo; Marina Cella; Fabio Facchetti; Marco Colonna; Michael A Caligiuri
Journal:  Blood       Date:  2002-12-12       Impact factor: 22.113

6.  Expansion of a unique CD57⁺NKG2Chi natural killer cell subset during acute human cytomegalovirus infection.

Authors:  Sandra Lopez-Vergès; Jeffrey M Milush; Brian S Schwartz; Marcelo J Pando; Jessica Jarjoura; Vanessa A York; Jeffrey P Houchins; Steve Miller; Sang-Mo Kang; Phillip J Norris; Douglas F Nixon; Lewis L Lanier
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-08       Impact factor: 11.205

Review 7.  Crosstalk between neutrophils and dendritic cells: a context-dependent process.

Authors:  Steffen Schuster; Benjamin Hurrell; Fabienne Tacchini-Cottier
Journal:  J Leukoc Biol       Date:  2012-12-18       Impact factor: 4.962

8.  Homeostatic proliferation generates long-lived natural killer cells that respond against viral infection.

Authors:  Joseph C Sun; Joshua N Beilke; Natalie A Bezman; Lewis L Lanier
Journal:  J Exp Med       Date:  2011-01-24       Impact factor: 14.307

9.  Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses.

Authors:  Silke Paust; Harvinder S Gill; Bao-Zhong Wang; Michael P Flynn; E Ashley Moseman; Balimkiz Senman; Marian Szczepanik; Amalio Telenti; Philip W Askenase; Richard W Compans; Ulrich H von Andrian
Journal:  Nat Immunol       Date:  2010-10-24       Impact factor: 25.606

10.  The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans.

Authors:  Cameron S Brandt; Myriam Baratin; Eugene C Yi; Jacob Kennedy; Zeren Gao; Brian Fox; Betty Haldeman; Craig D Ostrander; Tomonori Kaifu; Christian Chabannon; Alessandro Moretta; Robert West; Wenfeng Xu; Eric Vivier; Steven D Levin
Journal:  J Exp Med       Date:  2009-06-15       Impact factor: 14.307

View more
  146 in total

1.  The Human CD38 Monoclonal Antibody Daratumumab Shows Antitumor Activity and Hampers Leukemia-Microenvironment Interactions in Chronic Lymphocytic Leukemia.

Authors:  Alba Matas-Céspedes; Anna Vidal-Crespo; Vanina Rodriguez; Neus Villamor; Julio Delgado; Eva Giné; Heleia Roca-Ho; Pablo Menéndez; Elías Campo; Armando López-Guillermo; Dolors Colomer; Gaël Roué; Adrian Wiestner; Paul W H I Parren; Parul Doshi; Jeroen Lammerts van Bueren; Patricia Pérez-Galán
Journal:  Clin Cancer Res       Date:  2016-09-16       Impact factor: 12.531

2.  Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.

Authors:  Kening Wang; Georgia D Tomaras; Sinthujan Jegaskanda; M Anthony Moody; Hua-Xin Liao; Kyle N Goodman; Phillip W Berman; Supachai Rerks-Ngarm; Punnee Pitisuttithum; Sorachai Nitayapan; Jaranit Kaewkungwal; Barton F Haynes; Jeffrey I Cohen
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

3.  Characterization of a human anti-tumoral NK cell population expanded after BCG treatment of leukocytes.

Authors:  Eva M García-Cuesta; Gloria Esteso; Omodele Ashiru; Sheila López-Cobo; Mario Álvarez-Maestro; Ana Linares; Mei M Ho; Luis Martínez-Piñeiro; Hugh T Reyburn; Mar Valés-Gómez
Journal:  Oncoimmunology       Date:  2017-02-21       Impact factor: 8.110

Review 4.  Engineering Natural Killer Cells for Cancer Immunotherapy.

Authors:  Katayoun Rezvani; Rayne Rouce; Enli Liu; Elizabeth Shpall
Journal:  Mol Ther       Date:  2017-06-28       Impact factor: 11.454

5.  Favorable impact of natural killer cell reconstitution on chronic graft-versus-host disease and cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation.

Authors:  Vissal David Kheav; Marc Busson; Catherine Scieux; Régis Peffault de Latour; Guitta Maki; Philippe Haas; Marie-Christine Mazeron; Maryvonnick Carmagnat; Emeline Masson; Aliénor Xhaard; Marie Robin; Patricia Ribaud; Nicolas Dulphy; Pascale Loiseau; Dominique Charron; Gérard Socié; Antoine Toubert; Hélène Moins-Teisserenc
Journal:  Haematologica       Date:  2014-08-01       Impact factor: 9.941

Review 6.  Epigenetic Mechanisms Dictating Eradication of Cancer by Natural Killer Cells.

Authors:  Suresh Bugide; Radoslav Janostiak; Narendra Wajapeyee
Journal:  Trends Cancer       Date:  2018-07-03

Review 7.  Advances in targeted therapy for malignant lymphoma.

Authors:  Li Wang; Wei Qin; Yu-Jia Huo; Xiao Li; Qing Shi; John E J Rasko; Anne Janin; Wei-Li Zhao
Journal:  Signal Transduct Target Ther       Date:  2020-03-06

Review 8.  Advances in basic and clinical immunology in 2013.

Authors:  Javier Chinen; Luigi D Notarangelo; William T Shearer
Journal:  J Allergy Clin Immunol       Date:  2014-02-28       Impact factor: 10.793

9.  CRP polymorphisms and DNA methylation of the AIM2 gene influence associations between trauma exposure, PTSD, and C-reactive protein.

Authors:  M W Miller; H Maniates; E J Wolf; M W Logue; S A Schichman; A Stone; W Milberg; R McGlinchey
Journal:  Brain Behav Immun       Date:  2017-09-01       Impact factor: 7.217

10.  NK cell therapy for end-stage cancerous patient: A case study.

Authors:  Junichi Masuyama; Kamon Chaiyasit; Wanviput Sanphasitvong; Viroj Wiwanitkit
Journal:  South Asian J Cancer       Date:  2014-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.